Individuals will get:
- My weekly Edge column. TR anticipates trends and spots patterns that provide a knowledge advantage. The Edge runs Mondays. Sample headlines here, here, and here.
- My Frontpoints week in review. TR makes sure you don’t miss the most important news, deals, and shenanigans–with a dash of context and commentary. Frontpoints runs Fridays. Sample headlines here, here, and here.
- In-depth reports on the scientific, medical, financial & political aspects of industry, from an integrative thinker with 15 years covering the industry. Reports run regularly. Sample headlines here, here, and here.
- Exclusive commentary from insightful guest writers.
- No ads. Since there are no advertisers, there’s no need to design the site to suit their needs. That also means I won’t sell your data, won’t violate your privacy, and won’t waste your time. Enjoy a beautiful user experience designed only for you, the TR subscriber.
- Elite readers. Join a community of biotech’s leading thinkers and doers.
Subscriptions for individuals are $149 per year. That’s the best deal.
Want to try out Timmerman Report for a while? 3-month subscriptions are available for $50.
Over time, TR will help you find your next partner, next investment, or next job. Get it today!
Corporate site license
Companies can get a 10% discount off the regular rate of $149 per person per year by purchasing a group of subscriptions. Get one easy payment and one shared company login.
|Company size||Estimated # of readers||Price|
|50 employees or less||5||$670|
|Mid-to-Large Companies||20+||Customized, based on readership|
NOTE: Individual subscriptions cannot be shared; that is a copyright violation. By purchasing a corporate license, you obtain the right to share Timmerman Report content internally — not with anyone outside your company. Group subscribers may request PDF reprints of articles for internal posting.
Want to purchase a group subscription? Want the special academic discount, as an individual or for your institution? E-mail me at email@example.com.